Clinical trial
Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal…
NCT00208065 · Clinvest, Other · Completed
Key facts
| NCT number | NCT00208065 |
|---|---|
| Title | Evaluation of Histamine, CGRP and VIP as Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers |
| Official title | Evaluation of Histamine, CGRP and VIP as Biological Markers for Activation of Trigeminal and Parasympathetic Nerve Fibers in Response to "Sinus" Symptoms |
| Lead sponsor | Clinvest, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine, Sinusitis |
| Intervention type | Drug |
| Interventions | almotriptan or pseudoephedrine |
| Enrollment | 50 |
| Start date | May 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | May 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: